Geron (GERN)
(Delayed Data from NSDQ)
$2.94 USD
-0.04 (-1.34%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $2.94 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/26/2025
Time: -- |
12/2024 | $-0.03 | -140.00% |
Earnings Summary
For their last quarter, Geron (GERN) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 55.56%. Look out for GERN's next earnings release expected on February 26, 2025. For the next earning release, we expect the company to report earnings of -$0.03 per share, reflecting a year-over-year increase of 66.67%.
Earnings History
Price & Consensus
Zacks News for GERN
Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
GERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
GERN FAQs
Based on past history, Zacks believes Geron Corporation (GERN) will report their next quarter earnings on February 26, 2025. For the next earning release, we expect the company to report earnings of -0.03 per share, reflecting a year-over-year increase of 66.67.
Based on past history, Zacks believes Geron Corporation (GERN) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on February 26, 2025.
The Zacks Consensus Estimate for Geron Corporation (GERN) for the quarter ending in December 2024 is $-0.03 a share. We expect Geron Corporation to miss by -140.00%.
In the earnings report for the quarter ending in June 2024, Geron Corporation (GERN) announced earnings of $-0.10 per share versus the Zacks Consensus Estimate of $-0.11 per share, representing a surprise of -9.09%.